Is your company ready for the next financing round?
March 17, 2023
What you need to know about organizing finance in your life sciences company!
Join the upcoming Expert Class on April 21, 2023 at PwC in Amsterdam.
Join the Expert Class about stock options and long term incentives for founders
January 25, 2023
What you need to know as a founding team member about stock options and long term incentives.
Spatium Medical winner Investors Forum
December 02, 2022
During the Investors Forum 12 young companies had the opportunity to present their company to interesting partners and discuss their business strategy, technology direction and capital-raising plan. On stage of the 18th edition of the Dutch Life Sciences Conference, Spatium Medical became the proud winner of the Investors Forum Prize and was awarded a partnering ticket, national or international, with a total value of €2,500.
PrecorDx Wins the Venture Challenge Fall 2022!
December 02, 2022
The winner of the Venture Challenge was announced at the Dutch Life Sciences Conference. The proud winner of the 2022 spring edition is PrecorDx! The innovative startup PrecorDx has developed a non-invasive diagnostic platform aimed at reducing hospitalization & slowing disease progression in heart failure.
Presentations conference November 24, 2022 available!
December 01, 2022
Take a look at which presentations are available to be downloaded.
Pitching company River BioMedics in the spotlight
November 10, 2022
River BioMedics was founded on a novel, human iPSC-derived, 3D cardiac strip platform which represents human heart function, in an in vitro setting. The technology allows direct effects on human cardiac tissue of modification of drug target activity, to be measured at the very beginning of the drug discovery process. River exploits this in-house technology to validate novel cardiac drug discovery targets, identified from human genome wide association studies (GWAS) in heart failure.
Startups, join this Expert Class on Reimbursement for FREE
November 09, 2022
How to get reimbursement for your healthcare innovations
“Will my device or therapy get reimbursed?” has become critical, even for early development stage life sciences companies. From early investment rounds, investors want assurance of a return on their investment, and while they may not expect start-up companies to have all the reimbursement answers, they do expect companies to have identified the correct reimbursement questions.
Partner V.O. in the spotlight: How the patent of Ceradis contributes to Green Deal.
November 09, 2022
Ceradis has a sustainable mission: to enable farmers to produce food in a way that is safer for people and better for the environment. The company develops biological alternatives to protect crops. For years, V.O. has been the strategic partner in building their patent portfolio that is critical to their commercial success.